The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Meta Platforms META
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Meta Platforms, Inc.
read at $595.19
Meta Platforms holds its Markup at $595.19.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 10 days |
| Price | $595.19 |
| Valuation | 21.63 trailing · 16.08 forward price to earnings |
| Values screen | PASS · score 82.0 |
| Beta | 1.25 |
The opportunity · what the numbers say it is worth
Our framework reads OPPORTUNITY — it trades at roughly a 38% discount to our $818.96 fair value, strong competitive moat, 33.10% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 33.10% |
| Profit margin | 32.84% |
| Debt to equity | 35.61 |
| Analyst consensus | Strong Buy · 58 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 22.9% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 7.5% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 15.2% of assets, under the 49% limit. Pass
- Revenue purity Only 1.1% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
The ad machine paying for its own AI bet
Everyone knows Meta as Facebook and Instagram, and everyone worries about how much it is burning on the metaverse and AI. What gets lost in that worry: the core advertising business is a cash machine still growing over 30%, and it throws off enough profit to fund every one of those expensive bets and still look inexpensive.
Why it stands out. A dominant, wide-moat advertising franchise growing at 33% has no business trading at under 18 times forward earnings, but that is where it sits. Our fair value is around $810 against a price near $646, and unusually the analyst crowd lands in almost exactly the same place, at an $821 median. When our own model and the Street arrive at the same number from different directions, it is worth paying attention. It passes our ethical screen.
The honest risk. The AI and reality-labs spending is vast and still unproven, and regulatory and platform risk always hang over a business this dominant. If ad growth slows while the spending continues, the story shifts. Risk around 50%. Analysis, not advice.
| Forward P/E | 16.1x cheap for a company growing this fast |
| Trailing P/E | 21.6x a premium valuation |
| Revenue growth | 33.1% strong top-line growth |
| Profit margin | 32.8% highly profitable on every dollar of sales |
| Return on equity | 32.9% an exceptional return on shareholder capital |
| Debt to equity | 0.36 minimal debt — a conservative balance sheet |
| Current ratio | 2.35 comfortably covers its short-term bills |
| Beta | 1.25 moves a little more than the market |
| Market cap | $1.51T |
| Employees | 77,986 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on META
- › Research Firm Says Big Tech Earnings Just Flipped Valuation Risk GuruFocus.com · 16h ago
- › Meta Stock Rebounds as Amazon Revives AI Confidence GuruFocus.com · 17h ago
- › 5 Lessons From an Exhausting Week in Tech. And 2 Big Winners. Barrons.com · 17h ago
- › Wall Street To Big Tech: Show Us The Money In Pricey AI Race Investor's Business Daily · 17h ago
- › Big Tech Holds $2 Trillion of Spending Commitments for AI Boom Bloomberg · 17h ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in META's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
META trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | Mahoney Curtis J. | GC | Sale | 2,079 | $1,268,024 |
| 2026-05-18 | LI SUSAN J. | Chief Financial Officer | 11,322 | $6,904,533 | |
| 2026-05-18 | BOSWORTH ANDREW | Chief Technology Officer | 7,847 | $4,769,642 | |
| 2026-05-18 | OLIVAN JAVIER | Chief Operating Officer | 1,466 | $893,307 | |
| 2026-05-15 | KIMMITT ROBERT M | Director | 600 | · | |
| 2026-05-15 | ANDREESSEN MARC L | Director | 480 | · | |
| 2026-05-15 | TAN HOCK E | Director | 767 | · | |
| 2026-05-15 | TRAVIS TRACEY THOMAS | Director | 600 | · | |
| 2026-05-15 | SONGHURST CHARLES | Director | 709 | · | |
| 2026-05-15 | WHITE DANA | Director | 709 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 4 Jun2026 | John McGuire | Republican | buy | 1K–15K |
| 2026-05-05 | Brian Babin | Republican | Sale | 15K–50K |
| 2025-01-15 | Tim Moore | buy | 15000 | |
| 2024-11-10 | Ted Cruz | buy | 15000 | |
| 2024-10-15 | Maria Elvira Salazar | buy | 15000 |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $598.86 | -4.4% | · | $957 | -4.4% |
| 2 months | $629.86 | -9.1% | · | $909 | -9.1% |
| 3 months | $637.63 | -10.2% | $0.53 | $899 | -10.1% |
| 6 months | $651.62 | -12.1% | $1.05 | $881 | -11.9% |
| 1 year | $700.22 | -18.2% | $2.10 | $821 | -17.9% |
| 2 years | $499.22 | +14.7% | $4.13 | $1,156 | +15.6% |
| 3 years | $262.89 | +117.9% | $4.63 | $2,196 | +119.6% |
| 5 years | $328.68 | +74.3% | $4.63 | $1,757 | +75.7% |
Historical returns from market close data. Past performance does not guarantee future results.